It’s a potentially lifesaving treatment, altering the course of COVID: Monoclonal antibodies.
And an early new survey shows Black COVID patients aren’t being offered the coveted cocktail at the same rate as white patients.
Survey Indicates Black Patients Aren't Offered Antibody COVID Therapy
An early new survey shows Black COVID patients aren’t being offered antibody therapy at the same rate as white patients.
Posted
and last updated
Copyright 2024 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
